Health & Bio

Idvynso (HIV Combination) Approved April 21

FDA approved Idvynso for adult HIV-1—combining doravirine and islatravir as a novel antiretroviral regimen.

Primary sources · 1
Drugs.com
← View the full 2026-04-18 (Saturday) issue
What you're reading now arrives in your inbox daily at 21:00 UTC.

Get today's brief every day at 21:00 UTC

7 must-reads · 17 fields · tracked storylines delivered to your inbox daily. Pick only the fields you want; unsubscribe anytime.

Past issues →